You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Mark W. Leuchtenberger

President, Chief Executive Officer & Director at IRX Therapeutics, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Mark W. Leuchtenberger's strongest connections.

People Most Closely Connected to Mark W. Leuchtenberger

Click the names below to expand relationship details.
Harry H. Penner, Jr.
Founder at New Haven Pharmaceuticals, Inc.
Daniel M. Wechsler
President & Chief Executive Officer at Melinta Therapeutics, Inc.
Peter Feinstein
Co-Founder at Massachusetts Biotechnology Council
Garen Bohlin
Partner at Arthur Andersen
John W. Hadden II
Founder at IRX Therapeutics, Inc.
Daniel Katzman
Founder at NeuroHealing Pharmaceuticals, Inc.
Robert K. Coughlin
President & Chief Executive Officer at Massachusetts Biotechnology Council
Cecilia Gonzalo
Treasurer & Director at Harvard Business School Health Industry Alumni Association
Thomas Paul Koestler
Professional at Vatera Holdings
Lawrence M. Wolf
Former Partner at Arthur Andersen LLP
David N. Gill
President & Chief Financial Officer at EndoChoice Holdings, Inc.
Kevin Ferro
Chief Executive & Investment Officer at Vatera Holdings
Elkan R. Gamzu
Acting Head, Clinical Trials at NeuroHealing Pharmaceuticals, Inc.
John D. Halpern
Co-Founder at Halpern, Denny & Co.
John H. Johnson
Former Chief Executive Officer at ImClone Systems, Inc.
Charles R. Cherington
Co-Founder at Intervale Capital
Garheng Kong, M.D., Ph.D.
Founder at Healthquest Capital Management Co. Llc
George P. Denny III
Former Partner at Bain & Co., Inc.
There are 3,057 more people accessible only with RelSci Professional.